| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |
Operating costs and expenses | ||||||||||||
Research and development | ||||||||||||
12,371 | 6,495 | 7,122 | 6,506 | 5,674 | 6,018 | 3,821 | 1,781 | 2,938 | 1,426 | 619 | 324 | 321 |
General and administrative | ||||||||||||
2,625 | 1,918 | 2,012 | 2,129 | 1,745 | 1,295 | 1,298 | 1,463 | 1,348 | 1,100 | 298 | 241 | 208 |
Total operating expenses | ||||||||||||
14,996 | 8,413 | 9,134 | 8,635 | 7,419 | 7,313 | 5,119 | 3,244 | 4,286 | - | 917 | 565 | - |
Total operating expenses | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 529 |
Loss from operations | ||||||||||||
-14,996 | -8,413 | -9,134 | -8,635 | -7,419 | -7,313 | -5,119 | -3,244 | -4,286 | -2,526 | -917 | -565 | -529 |
Other income | ||||||||||||
Dividend and interest income, net | ||||||||||||
85 | 138 | 116 | 164 | 215 | 238 | 232 | 218 | 4 | - | - | - | - |
Net loss | ||||||||||||
-14,911 | -8,275 | -9,018 | -8,471 | -7,204 | -7,075 | -4,887 | -3,026 | -4,282 | -2,528 | -917 | -565 | -529 |
Net loss per share attributable to common stockholders basic and diluted | ||||||||||||
-0.79 | -0.45 | -0.57 | -0.54 | -0.46 | -0.45 | -0.31 | -0.19 | -0.37 | -0.25 | -0.10 | -0.06 | -0.06 |
Weighted average shares outstanding - basic and diluted | ||||||||||||
18,968 | 18,072 | 15,752 | 15,668 | 15,663 | 15,538 | 15,645 | 15,645 | 11,456 | 10,296 | 9,483 | 9,480 | 9,480 |